Identification of 371 genetic variants for age at first sex and birth linked to externalising behaviour.

"Competing interests: The main authors declare no competing interests. The views expressed in this article are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health. MMcC (Mark McCarthy) has served on advisory panels for Pfizer, NovoNordisk and Zoe Global, has received honoraria from Merck, Pfizer, Novo Nordisk and Eli Lilly, and research funding from Abbvie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, NovoNordisk, Pfizer, Roche, Sanofi Aventis, Servier, and Takeda. As of June 2019, MMcC is an employee of Genentech, and a holder of Roche stock."

"A detailed list of funding and other acknowledgments for each cohort can be found in Section 14 of the Supplementary Information. This research was conducted using the UK Biobank Resource under application 22276 and 9905. Funding was provided by the ERC to MC Mills SOCIOGENOME (615603) and CHRONO (835079), ESRC/UKRI SOCGEN (ES/N011856/1), Wellcome Trust ISSF, Leverhulme Trust, Leverhulme Centre for Demographic Science. N Barban with ERC GENPOP (865356), FC Tropf, LabEx Ecode, French National Research Agency (ANR) Investissements d’Avenir (ANR-11-LABX-0047). Marcel den Hoed Swedish Heart-Lung Foundation (20170872, 20200781, 20140543, 20170678, 20180706, 20200602), Kjell and Märta Beijer Foundation, Swedish Research Council (2015-03657, 2019-01417). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. This study received Ethical Approval from the Department of Sociology, University of Oxford and relevant Ethics approval was obtained at the local level for the contributing datasets. We thank Evelina T. Akimova and Stine Møllegaard for administrative work in the organization of the cohort information and author list."